Novavax CEO: FDA filing for COVID-19 vaccine is ‘probably going to be next week’

Novavax CEO Stanley Erck speaks with Yahoo Finance Live about the efficacy of Novavax vaccines and the path to FDA authorization amid a surge of the Omicron variant.